The illicit marketplace and related misuse of prescription drugs has expanded to deal with substitute substances [1], for instance New Psychoactive Substances (NPSs). NPSs comprise a heterogenous team of substances [2], such as prescription medication and investigate chemical compounds, which are not managed underneath the 1961 Single Conference on